Sally Del Principe
Corporate Officer/Principal chez Lupton del Principe Associates Ltd.
Postes actifs de Sally Del Principe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Lupton del Principe Associates Ltd. | Corporate Officer/Principal | 09/04/2010 | - |
Historique de carrière de Sally Del Principe
Anciens postes connus de Sally Del Principe
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
HIV-VAC, Inc.
 HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Directeur Financier/CFO | 09/04/2010 | 28/10/2010 |
Statistiques
Internationale
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
HIV-VAC, Inc.
HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA. | Commercial Services |
| Lupton del Principe Associates Ltd. |
- Bourse
- Insiders
- Sally Del Principe
- Expérience
